Identification and construction of combinatory cancer hallmark–based gene signature sets to predict recurrence and chemotherapy benefit in stage II colorectal cancer

From National Research Council Canada

DOIResolve DOI:
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: 2; Search for: 1
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
  2. National Research Council of Canada
FormatText, Article
Journal titleJAMA Oncology
Peer reviewedYes
NPARC number21276885
Export citationExport as RIS
Report a correctionReport a correction
Record identifier89cc6375-90f9-4186-a753-2e1e4933b7ad
Record created2015-10-30
Record modified2020-04-22
Date modified: